Marcin Feder at the Biotech and Bioinnovation Summit in Gdansk

20 October 2017

At the meeting, Adamed Group was represented by Marcin Feder, Head of In Silico laboratory at Adamed Group, who delivered a speech as part of the session entitled ‘Developing innovation in collaboration with industry’ and participated in the discussion panel ‘Partnership for innovation development’. Using the opportunity presented by this trip, Marcin Feder also accepted an invitation from the Biotech Boost Polska association and participated in a meeting with students and young scientists called Meet Biotech.

As part of the Meet Biotech meeting, Marcin Feder familiarised the participants with the characteristics of work at the Innovations Department, and gave a lecture entitled: ‘From an idea to the candidate for a drug. Development of particles ADO-21.32 and ADO-51.4 in Adamed laboratories’. His Bioinnovation International Summit 2017 speech however, was focused on the opportunities for cooperation between academic centres and start-ups with Adamed Group. Following that, during the discussion panel, Marcin Feder and Duncan Holmes of GSK presented the experiences of innovative pharmaceutical companies in cooperation with academic centres and centres for the transfer of technology. These experiences were discussed with Dr Andrzej Mogielnicki from the Medical University of Bialystok and Dr Ewelina Król from the Inter-University Department of Biotechnology of the University of Gdansk, and the Medical University of Gdansk. The speakers introduced the characteristics of such cooperation from the perspective of scientists conducting applied research projects.

The Meet Biotech meetings are organised by Boost Biotech, an association from Lodz, that aims to integrate communities connected with biotechnologies, i.e. people involved in scientific, business, marketing, and legal matters. They organise regular meetings with industry representatives and also promote university projects, thus creating a space for communication between science and business.

The Bioinnovation International Summit is an event that brings together technology transfer experts, innovative scientists, investors, and industry representatives. During the event, participants have the opportunity to learn about the pros and cons of the whole process of technology transfer, starting from an innovative idea, through negotiations with investors, obtaining external funding from public funds, and protecting intellectual property.

To read more about the events, go to:

2017 Bioinnovation International Summit -

Meet Biotech - Boost Biotech Polska –